Cargando…

Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact

BACKGROUND: Mycoplasma is a common cause of respiratory infections and may require differential diagnosis from Kawasaki disease (KD). In this study, we investigated the frequency and clinical manifestations of mycoplasma infection in patients with KD. MATERIALS AND METHODS: Medical records of 375 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hye Rim, Han, Mi Young, Yoon, Kyung Lim, Cha, Sung-Ho, Moon, Sung Kyoung, Jung, Hae Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382048/
https://www.ncbi.nlm.nih.gov/pubmed/28271651
http://dx.doi.org/10.3947/ic.2017.49.1.38
_version_ 1782520037153701888
author Park, Hye Rim
Han, Mi Young
Yoon, Kyung Lim
Cha, Sung-Ho
Moon, Sung Kyoung
Jung, Hae Woon
author_facet Park, Hye Rim
Han, Mi Young
Yoon, Kyung Lim
Cha, Sung-Ho
Moon, Sung Kyoung
Jung, Hae Woon
author_sort Park, Hye Rim
collection PubMed
description BACKGROUND: Mycoplasma is a common cause of respiratory infections and may require differential diagnosis from Kawasaki disease (KD). In this study, we investigated the frequency and clinical manifestations of mycoplasma infection in patients with KD. MATERIALS AND METHODS: Medical records of 375 in-patients admitted for treatment during the acute stage of KD, were collected, and reviewed retrospectively. Of these patients, 152 (40.5%) were also tested for recent mycoplasma infection. Patients with positive results (anti-mycoplasma IgM Ab >1:640 or cold agglutinin >1:64) were designated as the case group (n = 37, 24.3%) whereas those with negative results were designated as the control group (n = 115, 75.7%). Clinical findings of the two groups were compared. RESULTS: Patients in the case group were older than those in the control group (mean age, 48.2 ± 32.1 months, vs. 31.7 ± 21.7 months; P = 0.001). There were significant differences between the case and control groups in the changes in the extremities (78.3% vs. 57.4%, respectively; P = 0.031), and in fever duration (6.5 ± 2.5 days vs. 5.4 ± 1.5 days; P = 0.047). Of the 37 patients with positive mycoplasma testing, 7 (18.9%) had persistent fever even after the symptoms and signs of systemic inflammation (acute phase of KD) had been resolved. These patients were positive for mycoplasma infection during further evaluation of persistent fever, and all of them responded to macrolide antibiotics. CONCLUSIONS: We found that mycoplasma infection is somewhat related to KD. When fever persists after resolution of the acute stage of KD, mycoplasma infection may be considered as a possible cause of fever in preschool-aged children.
format Online
Article
Text
id pubmed-5382048
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
record_format MEDLINE/PubMed
spelling pubmed-53820482017-04-06 Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact Park, Hye Rim Han, Mi Young Yoon, Kyung Lim Cha, Sung-Ho Moon, Sung Kyoung Jung, Hae Woon Infect Chemother Original Article BACKGROUND: Mycoplasma is a common cause of respiratory infections and may require differential diagnosis from Kawasaki disease (KD). In this study, we investigated the frequency and clinical manifestations of mycoplasma infection in patients with KD. MATERIALS AND METHODS: Medical records of 375 in-patients admitted for treatment during the acute stage of KD, were collected, and reviewed retrospectively. Of these patients, 152 (40.5%) were also tested for recent mycoplasma infection. Patients with positive results (anti-mycoplasma IgM Ab >1:640 or cold agglutinin >1:64) were designated as the case group (n = 37, 24.3%) whereas those with negative results were designated as the control group (n = 115, 75.7%). Clinical findings of the two groups were compared. RESULTS: Patients in the case group were older than those in the control group (mean age, 48.2 ± 32.1 months, vs. 31.7 ± 21.7 months; P = 0.001). There were significant differences between the case and control groups in the changes in the extremities (78.3% vs. 57.4%, respectively; P = 0.031), and in fever duration (6.5 ± 2.5 days vs. 5.4 ± 1.5 days; P = 0.047). Of the 37 patients with positive mycoplasma testing, 7 (18.9%) had persistent fever even after the symptoms and signs of systemic inflammation (acute phase of KD) had been resolved. These patients were positive for mycoplasma infection during further evaluation of persistent fever, and all of them responded to macrolide antibiotics. CONCLUSIONS: We found that mycoplasma infection is somewhat related to KD. When fever persists after resolution of the acute stage of KD, mycoplasma infection may be considered as a possible cause of fever in preschool-aged children. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2017-03 2017-02-28 /pmc/articles/PMC5382048/ /pubmed/28271651 http://dx.doi.org/10.3947/ic.2017.49.1.38 Text en Copyright © 2017 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Hye Rim
Han, Mi Young
Yoon, Kyung Lim
Cha, Sung-Ho
Moon, Sung Kyoung
Jung, Hae Woon
Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
title Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
title_full Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
title_fullStr Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
title_full_unstemmed Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
title_short Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
title_sort mycoplasma infection as a cause of persistent fever after intravenous immunoglobulin treatment of patients with kawasaki disease: frequency and clinical impact
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382048/
https://www.ncbi.nlm.nih.gov/pubmed/28271651
http://dx.doi.org/10.3947/ic.2017.49.1.38
work_keys_str_mv AT parkhyerim mycoplasmainfectionasacauseofpersistentfeverafterintravenousimmunoglobulintreatmentofpatientswithkawasakidiseasefrequencyandclinicalimpact
AT hanmiyoung mycoplasmainfectionasacauseofpersistentfeverafterintravenousimmunoglobulintreatmentofpatientswithkawasakidiseasefrequencyandclinicalimpact
AT yoonkyunglim mycoplasmainfectionasacauseofpersistentfeverafterintravenousimmunoglobulintreatmentofpatientswithkawasakidiseasefrequencyandclinicalimpact
AT chasungho mycoplasmainfectionasacauseofpersistentfeverafterintravenousimmunoglobulintreatmentofpatientswithkawasakidiseasefrequencyandclinicalimpact
AT moonsungkyoung mycoplasmainfectionasacauseofpersistentfeverafterintravenousimmunoglobulintreatmentofpatientswithkawasakidiseasefrequencyandclinicalimpact
AT junghaewoon mycoplasmainfectionasacauseofpersistentfeverafterintravenousimmunoglobulintreatmentofpatientswithkawasakidiseasefrequencyandclinicalimpact